SCHEMBL830154

SCHEMBL830154

COc1ccc(CS(=O)(=O)c2cc3ccc(OC)cc3sc2=O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.42
SIRT2 Q8IXJ6 1/20 0.41
PTGS2 P35354 1/20 0.41
PLCG1 P19174 1/20 0.40
TXNRD1 Q16881 1/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 2/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
CSNK1D P48730 1/20 0.38
CYP2C9 P11712 1/20 0.38
HTT P42858 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA9 Q16790 1/20 0.38
HDAC1 Q13547 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL830672 0.90 SULT1A1 (0.43) CA2L3MBTL1SIRT2PLCG1ALDH1A1
SCHEMBL830871 0.90 MEN1 (0.42) CA2L3MBTL1SIRT2PLCG1TXNRD1
SCHEMBL830994 0.89 GCKR (0.42) L3MBTL1PLCG1ALDH1A1MAPTCYP1A2
SCHEMBL830259 0.87 CA2 (0.54) CA2PTGS2CYP1A2CYP2C19CA12
SCHEMBL830177 0.83 MEN1 (0.42) CA2L3MBTL1PLCG1ALDH1A1MAPT
SCHEMBL830855 0.83 CA2 (0.40) CA2L3MBTL1PLCG1TXNRD1HDAC1
SCHEMBL830099 0.83 TXNRD1 (0.42) CA2TXNRD1ALDH1A1CYP1A2CYP2C19
SCHEMBL830049 0.82 CA2 (0.57) CA2ALDH1A1CYP1A2CYP2C19CA12
SCHEMBL830244 0.81 ALDH1A1 (0.45) L3MBTL1PLCG1TXNRD1ALDH1A1MAPT
SCHEMBL831848 0.78 CA2 (0.43) CA2PTGS2CYP1A2KDM4EPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143428-B2 Heteroaryl sulfones and sulfonamides and therapeutic uses thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2012-03-27 US claimed
US-20070232649-A1 Heteroaryl Sulfones and Sulfonamides and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2007-10-04 US claimed
EP-1765804-A2 HETEROARYL SULFONES AND SULFONAMIDES AND THERAPEUTIC USES THEREOF Temple University of the Commonwealth System of Higher Education (US) 2007-03-28 EP claimed
WO-2005123077-A2 HETEROARYL SULFONES AND SULFONAMIDES AND THERAPEUTIC USES THEREOF TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2005-12-29 WO claimed
US-8143428-B2 Heteroaryl sulfones and sulfonamides and therapeutic uses thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2012-03-27 US disclosed
US-20070232649-A1 Heteroaryl Sulfones and Sulfonamides and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232649-A1 Heteroaryl Sulfones and Sulfonamides and Therapeutic Uses Thereof SULT1E1, STS, CCNE1 CA2 2552/4885L3MBTL1 2204/4885SIRT2 846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.